baber/WOPTO huggingface dataset:
Patent PT-1189972-E (PT)
Title: Process for preparing reduced byproduct polyamine-epihalohydrin resins
Inventor: CRISP MARK T
IPC: D21H27/10
Filed: 2000-06-12
Abstract: A storage stable polyaminopolyamide-epihalohydrin resin, said resin, when stored as an aqueous composition containing the resin, and when stored at pH 1 for 24 hours at 50 °C and measured at 24 hours, produces less than about 1000 ppm dry basis of CPD; said resin being produced from a reaction of a) polyaminoamide prepolymer having an acid functionality of less than about 0.5 milliequivalents/dry gram of prepolymer and b) epihalohydrin, said prepolymer being end-capped prior to reaction with epihalohydrin by reaction with an endcapping agent.
Patent PT-1282690-E (PT)
Inventor: FRANK LUYTEN
IPC: A61K35/12
Filed: 2000-10-06
Abstract: Positively identifying viable precursor cells that have entered a post-natal differentiation pathway comprises using reagents, ligands and/or antibodies to recognize an embryonic cell surface marker such as an expressed morphogenic protein, its homolog or a marker co-expressed and/or co-detectable with this marker, so as to sort and enrich the precursor cells. Independent claims are also included for: (1) producing or repairing connective tissue in a mammal by using skeletal precursor cells (I), marked with an expressed morphogenic protein, its homologs or co-expressed and/or co-detectable markers e.g. FGFR3 (fibroblast growth factor receptor 3), a gene, protein or mRNA expressed in the precursor cells; (2) using (I) as a source of growth factors; (3) a culture of viable precursor cells (II) that have entered a specific post-natal differentiation pathway and which express an embryonic marker which is an expressed morphogenic protein, its homolog or a marker co-expressed and/or co-detectable with this marker; (4) an implant (III) comprising (II), especially skeletal precursor cells; and (5) a diagnostic for identifying a positive marker of (II).
Patent PT-1207237-E (PT)
IPC: E04B1/348
Filed: 2001-10-26
Abstract: The prefabricated room cell is made from concrete and comprises a base plate (2), ceiling plate (3) and side walls (4). At least the walls (4) are cast as a monolith from concrete and on one side there is a concealed shuttering which has plates (8) of concrete provided with a flat surface reinforcement. Further elements such as webs or grid supports protruding from the concrete plates project into the concrete used to cast the walls. At least one wall is thicker than its opposite wall.
Patent PT-1272504-E (PT)
Title: 8beta-hydrocarbyl-substituted estratrienes for use as selective estrogens
Inventor: THIEME INA
IPC: A61P15/02
Filed: 2001-04-12
Abstract: This invention describes the new 8beta-substituted estratrienes of general formula I in which R<SUP>2</SUP>, R<SUP>3</SUP>, R<SUP>6</SUP>, R<SUP>6'</SUP>, R<SUP>7</SUP>, R<SUP>7'</SUP>, R<SUP>9</SUP>, R<SUP>11</SUP>, R<SUP>11'</SUP>, R<SUP>12</SUP>, R<SUP>14</SUP>, R<SUP>15</SUP>, R<SUP>15'</SUP>, R<SUP>16</SUP>, R<SUP>16'</SUP>, R<SUP>17</SUP>, R<SUP>17'</SUP> have the meanings that are indicated in the description, and R<SUP>8 </SUP>means a straight-chain or branched-chain, optionally partially or completely halogenated alkyl or alkenyl radical with up to 5 carbon atoms, an ethinyl- or prop-1-inyl radical, as pharmaceutical active ingredients that have in vitro a higher affinity to estrogen receptor preparations of rat prostates than to estrogen receptor preparations of rat uteri and in vivo preferably a preferential action on bone rather than the uterus and/or a pronounced action with respect to stimulation of the expression of 5HT2a-receptors and 5HT2a-transporters, their production, their therapeutic use and pharmaceutical dispensing forms that contain the new compounds. The invention also describes the use of these compounds for treatment of estrogen-deficiency-induced diseases and conditions as well as the use of an 8beta-substituted estratriene structural part in the total structures of compounds that have a dissociation in favor of their estrogenic action on bones rather than the uterus.
Patent PT-1326643-E (PT)
Inventor: COWLES VERNE E
IPC: A61K31/46
Filed: 2001-10-16
Abstract: Metformin is formulated as a pharmaceutical composition that also includes a 5-hydroxytryptamine-3 receptor antagonist to suppress the gastrointestinal side effects that are associated with metformin administration in many patients.
Patent PT-1232743-E (PT)
Inventor: JACQUES LECLERE
IPC: A61K8/63
Filed: 2002-02-12
Abstract: Cosmetic or dermatological composition producing a refreshing effect when applied topically or externally comprises magnesium aspartate.
Patent PT-1416935-E (PT)
Title: 4-amino-6-phenyl-pyrrolo[2,3-d]pyrimidine derivatives
Inventor: CAPRARO HANS-GEORG
IPC: C07D487/04
Filed: 2002-08-06
Abstract: The invention relates to 7H-pyrrolo[2,3-d]pyrimidine derivatives of formula I wherein the symbols and substituents are as defined in the description, to processes for the preparation thereof, to pharmaceutical compositions comprising such derivatives and to the use of such derivatives-alone or in combination with one or more other pharmaceutically active compounds-for the preparation of pharmaceutical compositions for the treatment especially of a proliferative disease, such as a tumour.
Patent PT-1412317-E (PT)
Title: Retinoid derivatives with antiangiogenic, antitumor and proapoptotic activities
Inventor: PENCO SERGIO
IPC: C07F7/18
Filed: 2002-07-18
Abstract: Are described compounds of Formula (I) in which R, R′, R″, A, and D have the meanings described in the text, as useful agents in the cure of pathologies characterized by altered angiogenesis and as antitumorals.
Patent PT-1422118-E (PT)
Title: Railway vehicle, especially light motor car
Inventor: BOLINTH HANS
IPC: B61D15/06
Filed: 2003-10-22
Abstract: The railway wagon, and especially a light railcar, has a head section (3a) as a self-supporting unit for the driver, and a shell (2) for the passenger compartment. Telescopic buffers are under the head section to absorb impact energy on a collision, with a reversible stage (1a) and an irreversible stage (1b), shrouded by an apron (4) at the front.
Patent PT-1545866-E (PT)
Title: An automatic control and monitoring system for splice overlapping tolerance in textile ply
Inventor: PUGA ANDRE TEIXEIRA
IPC: G01B11/06
Filed: 2003-08-29
Abstract: The present system enables the monitoring and automatic control of the tolerance in splice overlap of textile play , though the identification of the overlap area, identification and counting of textile cords in the overlap area, and the generation of a control signal for the manufacturing equipment based on parameters and criteria defined by a user. The system includes an image acquisition sub-assembly that contains a lighting module, artificial vision module, and respective elements of support, fixation, conditioning and adjustment. The system also includes a quality control computer program that has a module of morphologic image analysis for detection and recognition of the overlap of the ply, detecting and counting of cords in the overlap area, a module of support to the decision of acceptance/rejection of the ply based on parameters defined by the user and a module of an interface with production equipment.
Patent PT-1605608-E (PT)
Title: Mobile communication system for use on board a ship using a satellite link.
Inventor: NOMINE-BEGUIN ROCH-ALEXANDRE
IPC: H04B7/185
Filed: 2004-06-11
Abstract: The invention relates to a telecommunication system for use on board a ship for setting up communications with ground networks (400), the telecommunication system including at least one base transceiver station (10) for setting up radio links with mobile stations (1) located on board the ship and a satellite station (110) for setting up communications between the on board telecommunication system and a ground station (310) via a satellite link,   characterized in that it also comprises an acknowledgment device (120) adapted for generating and transmitting an acknowledgement signal to the base transceiver station (10) in response to a mobile station (1) located on board the ship sending a frame to be transmitted by the telecommunication system to the ground station (310).
Patent PT-1604065-E (PT)
Title: Method of repairing a railway rail anchor on a wooden sleeper and insert used for performing the method
Inventor: MAHIKIAN EDMOND
IPC: F16B13/02
Filed: 2004-03-08
Abstract: The procedure consists of withdrawing the rail anchoring bolt from its hole in the sleeper (2) and putting in a semi-tubular insert (5) of a moulded synthetic material with holes through it. A wood fibre penetrating self-hardening fluid (17) is then injected into the hole from a container (18) with a nozzle (19). Finally, the bolt is replaced, squeezing the insert against the wall of the hole and forcing the fluid through its holes. The procedure consists of withdrawing the rail anchoring bolt from its hole in the sleeper (2) and putting in a semi-tubular insert (5) of a moulded synthetic material that is slightly shorter than the depth of the sleeper hole and has holes through it. A self-hardening fluid (17) that can penetrate the wood fibres before it sets is then injected into the hole from a container (18) with a nozzle (19). Finally, the bolt is replaced, squeezing the insert against the wall of the hole and forcing the fluid through its holes.
Patent PT-1684805-E (PT)
Title: Use of antagonist anti-cd40 monoclonal antibodies for treatment of multiple myeloma
Inventor: LONG LI
IPC: C07K16/28
Filed: 2004-11-04
Abstract: Methods of therapy for treating a subject for multiple myeloma are provided. The methods comprise administering a therapeutically effective amount of an antagonist anti-CD40 antibody or antigen-binding fragment thereof to a patient in need thereof. The antagonist anti-CD40 antibody or antigen-binding fragment thereof is free of significant agonist activity, but exhibits antagonist activity when the antibody binds a CD40 antigen on a human CD40-expressing cell. Antagonist activity of the anti- antibody or antigen-binding fragment thereof beneficially inhibits proliferation and/or differentiation of human CD40 expressing multiple myeloma cells.
Patent PT-1718651-E (PT)
Title: 7h-pyrrolopyrimidine derivatives
Inventor: CARAVATTI GIORGIO
IPC: A61K31/519
Filed: 2005-02-17
Abstract: The invention relates to 7H-pyrrolo[2,3-d]-pyrimidine derivatives of formula (I), wherein the symbols and substituents are as defined in the description, to processes for the preparation thereof to pharmaceutical compositions comprising such derivatives and to the use of such derivatives-alone or in combination with one or more other pharmaceutically active compounds -for the preparation of pharmaceutical compositions for the treatment especially of a proliferative disease, such as a tumor.
Patent PT-1749448-E (PT)
Title: Product which is fermented without lactose from a shake comprising non-vegetable dried fruits and/or orgeat
Inventor: MARTINEZ GASPAR PEREZ
IPC: A23L33/00
Filed: 2005-04-27
Abstract: The invention relates to products which are fermented with probiotic lactic bacteria from milk or a shake comprising almonds (Prunus Amygdalus, var. dulcis), other non-vegetable dried fruits or orgeat obtained from chufa tubers (Cyperus esculentus). The inventive products deliver the nutritional benefits of the dried fruits, the orgeat and the added probiotic bacteria, with a unique flavour and a consistency, acidity and aroma similar to yoghurt. Optionally, if the sugar content is kept low, the products have astringent and intestinal flora reestablishment properties. In addition, the products can be combined with additives and flavours and enriched with minerals, vitamins, fibre or oligosaccharides having a bifidogenic effect, etc., or pasteurised following fermentation. In almost all cases, the products form an excellent nutritional supplement for adolescents, athletes or elderly persons.
Patent PT-640355-E (PT)
Inventor: BOUSSIGNAC GEORGES
IPC: A61M16/04
Filed: 1994-07-29
Abstract: - Respiratory assistance tube (2), the distal end (3) of which is intended to be introduced into the trachea (4) of a patient and is provided with an inflatable balloon (5) for making a seal between the said respiratory assistance tube and the said trachea, and the proximal end of which is intended to be connected to means (7, 8) for feeding respiratory gas into the lungs of the patient, via the said tube. - According to the invention, the said respiratory assistance tube comprises at least one duct (10) passing through the wall of the said tube (2) and establishing communication (10) between the interior (9) of the said tube and the interior (6) of the said balloon (5), as well as a longitudinal duct (17) emerging in the cavity (6) and connecting the latter to the outside of the patient. <IMAGE>
Patent PT-679191-E (PT)
Inventor: SPRIGGS MELANIE K
IPC: A61K35/12
Filed: 1994-01-21
Abstract: CD4+ cells obtained from individuals with defective CD40L gene and transfected with a vector containing CD40-L are described.
Patent PT-772420-E (PT)
Inventor: FACCIOLI GIOVANNI
IPC: A61B17/17
Filed: 1995-07-12
Abstract: A blind-hole locating system wherein a drill jig, which is to be removably attached to the proximal end of a given intramedullary nail, incorporates outrigger structure for support and orientation of one or more drill guides, such that positioning and alignment with one or more bone-screw holes of the nail can be checked and ascertained as a preliminary step, and such that a precise spacer or stabilizer carried by this jig can be known to contact the nail, on an alignment transverse to the nail and to a geometric plane which includes the nail axis and the axis of at least one of the bone-screw holes of the nail, such stabilizer contact being achieved only for the case of correct drill-guide alignment with one or more bone-screw holes. Having thus ascertained that the spacer correctly identifies drill-guide alignment with bone-screw holes, it is only necessary, after installing the nail and connecting the jig to the proximal end of the nail, to make a small local surgical incision through flesh and bone sufficient to enable direct stabilizer contact with the nail, whereupon it is known that the drill guides are in correctly drillable alignment with the targeted bone-screw holes of the installed nail. Drilling and setting of bone screws can immediately proceed in customary manner.
Patent PT-801560-E (PT)
Inventor: RORK GERALD S
IPC: A61K9/24
Filed: 1995-12-18
Abstract: A device is disclosed for the controlled delivery of a beneficial agent, the device consisting of (i) a core comprising at least two layers, wherein at least one layer comprises a beneficial agent and a polymer which forms microscopic gel beads upon hydration and at least one layer which comprises a polymer which forms microscopic gel beads upon hydration; and (ii) an impermeable, insoluble coating which adheres to and surrounds the core and contains apertures which provide an area for the hydration and release of the microscopic gel beads.
Patent PT-781699-E (PT)
Inventor: VREE JOHANNES DE
IPC: B62D61/10
Filed: 1996-12-18
Abstract: The invention relates to a self-propelling vehicle (1) which can be used particularly on agricultural land and which is provided with a plurality of wheel pairs (4,5,6), wherein the wheels of each pair are coupled by a shaft (7,8,9), and with drive means coupled to at least one wheel pair (4,5,6). In order to provide a self-propelling vehicle (1) which is suitable for travel both on the public highway and on for instance agricultural land, at least one of the wheel pairs (4,5,6) is displaceable in the direction roughly transversely of the longitudinal direction of the vehicle (1). <IMAGE>
Patent PT-876329-E (PT)
Inventor: BOMMARIUS ANDREAS
IPC: C07C233/47
Filed: 1996-12-05
Abstract: Known acetylation processes for producing N-acetyl-D,L- alpha -aminocarboxylic acids from the corresponding D,L- alpha -aminocarboxylic acids by acetylation with acetic anhydride in acetic acid and isolation of the resulting N-acetyl-D,L- alpha -aminocarboxylic acids from the acetylation mixture either result in the production of large quantities of salts or require an aqueous treatment to isolate the N-acetylated  alpha -amino acids in sufficiently pure form. By carrying out the acetylation at 60-150  DEG C in a concentration of < 3 mol  alpha -aminocarboxylic acid per litre acetic acid (concentration under standard conditions of pressure and temperature) and obtaining the N-acetyl-D,L- alpha -aminocarboxylic acid by concentration in liquefied or solid form, the aqueous treatment can be dispensed with entirely, although high quality is still obtained in terms of both yield and purity. Also disclosed are N-acetyl-D,L- alpha -aminocarboxylic acids for use in the enzymatic splitting operation in a process for producing optically active  alpha -aminocarboxylic acids.
Patent PT-1007263-E (PT)
Inventor: SIMPSON STEPHEN WALTER
IPC: B23K9/09
Filed: 1998-04-08
Abstract: This invention concerns weld quality measurement. In particular it concerns an apparatus and a process for measuring on-line, while the welding process is under way, the quality of the resulting weldment. The invention is applicable to spray-transfer gas-metal arc welding, short-circuiting transfer gas-metal arc welding, pulse welding, radio-frequency resistance welding and submerged arc welding. It involves the measurement of voltage or current and the generation of an artificial signal for the other. A two dimensional signal analysis then produces data for comparison with data obtained from a high quality weld.
Patent PT-973895-E (PT)
Title: Transcription factor islet-brain 1 (ib1)
Inventor: WAEBER GERARD
IPC: C07K14/47
Filed: 1998-04-02
Abstract: The identification and characterisation of human and rat Islet-Brain 1 (IB1) is disclosed, a transcriptional activator that is involved in the control of the GLUT2 and insulin genes by interacting with homologous cis-regulatory elements of the GLUT2 and insulin promoters. The rat IB1 cDNA encodes a 714 amino acid protein and the human IB1 cDNA a 711 amino acid protein. The use of IB1 polypeptides, nucleic acid, agonists and antagonists in the treatment or diagnosis of diabetes, neurological diseases such as dementia and/or parkinsonism, the inhibition/promotion of apoptosis and cancer is disclosed.
Patent PT-993612-E (PT)
Title: Method and apparatus for marking and identifying liquids
Inventor: ASHER WILLIAM E
IPC: C10L1/16
Filed: 1998-06-30
Abstract: A liquid can be marked for identification purposes with at least first and second miscible markers. The markers are mixed in the liquid so that the ratio of the concentration of the first marker to the concentration of the second marker is substantially equal to a predetermined value. Thus, by comparing the ratio of the measured concentration of the first marker to the measured concentration of the second marker with predetermined values the liquid can be uniquely identified. The detectors can be connected to a processor and control unit ( 22 ) for initiation of testing, for processing of detection signal from the detectors, and for display of readout information. Processor and control unit ( 22 ) can include a look up table ( 23 ) for storing information about marking patterns, a comparison element ( 35 ) for comparing measured values with values supplied by look up table ( 23 ), and a display ( 30 ).
Patent PT-1171544-E (PT)
Inventor: KATHIRGAMANATHAN POOPATHY
IPC: H01L51/50
Filed: 1999-12-01
Abstract: Tb(TMHD)3OPNP where TMHD is 2,2,6,6-tetramethyl-3,5-heptanedionato and OPNP is diphenylphosphonimide triphenyl phosphorane is an electroluminescent material which emits white light at an applied voltage of above 12 volts.
Patent IE-830121-L (IE)
Title: Cigarette smoke filter
IPC: A24D3/04
Filed: 1983-01-21
Abstract: A smoke filter (3) for a smoking article (e.g. a cigarette) comprises a filter plug (3) having ducts (5) extending part way along the plug from the mouth end thereof, and opening in register with inlets (9) through wrapping means (7) around the plug (4) to provide segregated peripheral venting of the filter. Further apertures (10) in the wrapping means (7) communicate directly with the filter plug away from the ducts (5), to permit ambient air to enter the filter plug to mix with and dilute the smoke being filtered within the plug. In one embodiment of the invention mixing of ambient air with smoke being filtered within the plug is facilitated by provision of a circumferentially extending channel (13) which is in register with said further apertures. <IMAGE>
[GB2116824A]
Patent IE-800124-L (IE)
Title: Vehicle speed control system.
IPC: F02D41/10
Filed: 1980-01-22
Abstract: A vehicle speed control system is disclosed where the vehicle speed is automatically controlled by an electro-pneumatic actuator subjected to the controlled application of sub-atmospheric pressure. A dump valve is normally held closed by an energized electrical coil but opens when the coil is de-energized and connects the actuator to atmosphere and shuts off the control system. The coil is connected to an electrical power source through a disabling switch which is intended to be opened automatically when the driver operates the vehicle brakes and thus overrides the control system. To ensure that the override is effective even if the disabling switch fails to open, a brake-pedal operated switch connects one end of the coil to the same terminal of the power supply as is connected to the other end of the coil by the disabling switch. Therefore, when the brakes are operated both sides of the coil receive the same potential and the coil is de-energized even if the disabling switch fails to open.
[US4312419A]
Patent IE-890201-L (IE)
Title: Pyrrolidinones
IPC: A61K31/4015
Filed: 1989-01-24
Abstract: There are disclosed compounds of the formula <CHEM> where R1 is loweralkoxycarbonyl, -CH2OH or -CONR3R4, R3 and R4 being independently hydrogen, loweralkyl or arylloweralkyl; and R2 is -CH2CH=CH2, <CHEM> R5 and R6 being independently loweralkyl or alternatively the group -NR5R6 as a whole being <CHEM> R7 being hydrogen, loweralkyl or arylloweralkyl; and a process for their preparation. The compounds are useful for enhancing cholinergic activity in mammals and hence for the treatment of various memory dysfunctions characterized by decreased cholinergic function such as Alzheimer's disease, and can, therefore, be used as medicaments.
[EP0325984A2]
Patent IE-790320-L (IE)
Title: Bottle inspection equipment
IPC: G01N21/90
Filed: 1979-02-26
Abstract: This invention concerns an apparatus for detecting the presence of faults in a translucent container of the kind comprising a scanning zone in which a translucent container is rotated while being repeatedly scanned by a spot beam of light in a direction parallel to the axis of rotation of the container, a light collection apparatus being arranged to receive light from the beam after passing through the container. The light collection apparatus comprises a rectangular matrix of photosensitive devices disposed behind a light-diffusing screen upon whose front surface the light from the scanning beam falls after passing through the container. A rectangular grid of thin white walls is sandwiched between the screen and the photosensitive devices so as to define a plurality of boxes with a respective device being located at the rear of each box. The grid thus effectively divides the screen into a large number of elemental areas and provides that each device receives light substantially only from a respective elemental area of the screen. This invention permits the detection of certain nonocclusive refraction faults in the translucent container by selective examination of the device outputs, as well as the detection of occlusive faults by measurement of the total light falling on the screen.
[US4338028A]